首頁 > 市場調查報告書 > 製藥

OTC 非處方藥

市場調查報告書

商品編碼

1541557

2024-2032年按產品類型（祛痰藥、止咳藥/鎮咳藥、聯合用藥）、年齡層（兒童、成人）、配銷通路（零售藥房、醫院藥房、在線藥房）和地區分類的止咳糖漿市場報告

Cough Syrup Market Report by Product Type (Expectorants, Cough Suppressants/Antitussives, Combination Medications), Age Group (Pediatric, Adult), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and Region 2024-2032

出版日期: 2024年08月10日 | 出版商:

IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年全球止咳糖漿市場規模達59億美元。上呼吸道感染（URTI）和其他呼吸系統疾病的發生率不斷增加，以及在雜貨店和藥局容易買到止咳糖漿，主要推動了市場的成長。

全球止咳糖漿市場分析：

主要市場促進因素：更容易患呼吸系統疾病的老年人口的不斷增加是市場的主要驅動力。此外，個人健康意識的增強也是另一個重要的成長誘導因素。

主要市場趨勢：產品製造商正在推出採用天然成分和草藥強化的增強型產品，具有增強免疫力的作用，這是推動全球市場的主要趨勢之一。除此之外，副作用最小的止咳糖漿的推出進一步增強了市場。

地理趨勢：由於該地區個人醫療保健支出能力的提高，亞太地區目前在全球市場中佔據主導地位。除此之外，對咳嗽藥物的日益關注正在對市場成長產生積極影響。

競爭格局：一些著名的止咳糖漿市場公司包括Acella Pharmaceuticals LLC、拜耳AG、葛蘭素史克PLC、強生公司、輝瑞公司、Prestige Consumer Healthcare Inc.、利潔時集團PLC、賽諾菲、太陽製藥工業有限公司和寶潔公司等。

挑戰與機會：主要挑戰，例如應對複雜監管環境的需求不斷增加，以及對濫用和誤用含有鴉片類藥物或其他精神活性成分的止咳糖漿的日益擔憂，正在阻礙整個市場。然而，製藥業的持續成長將在未來幾年繼續推動全球市場。

全球止咳糖漿市場趨勢：

日益嚴重的醫療狀況

感冒、流感、支氣管炎、百日咳、氣喘、慢性肺阻塞性疾病 (COPD) 和過敏的盛行率不斷上升，推動了對止咳糖漿的需求。例如，根據《經濟時報》2023 年發表的一篇文章，全球約有 3.39 億人受到氣喘影響。此外，由於菸草消費的增加和不健康的生活方式，咳嗽病例的增加也刺激了市場的成長。除此之外，根據世界衛生組織 (WHO) 的數據，每年有超過 800 萬人因吸菸而過早死亡。其中，700萬是直接吸菸者，170萬是二手菸者。因此，政府和非政府組織正在發起眾多計劃和活動，以提高人民的意識。例如，2023 年 7 月，澳洲肺臟基金會發起了一項慢性咳嗽宣傳活動，以提高成人和兒科的認知並支持診斷。除此之外，不斷擴大的老年人口進一步影響了止咳糖漿的市場前景。例如，根據世界衛生組織的數據，2020年60歲及以上的人口將達到10億，預計2050年將達到21億人。

政府機構的監管環境

各國監管機構正在實施嚴格的規定，以確保止咳糖漿的領先公司遵守高醫療標準。據此，他們正在提高醫療保健專業人員開發學名藥的意識，從而催化止咳糖漿市場的近期機會。例如，在寫給所有邦和中央直轄區的一封信中，印度藥品監管總局（DCGI）要求確保印度生產的止咳糖漿達到全球標準質量，並對其進行詳細驗證。為此，他要求對丙二醇（PG）製造商、止咳糖漿製造商和進口商進行聯合核查，以確保用於製造止咳糖漿的原料或供應符合全球協議。此外，世界衛生組織（WHO）也指出另一種止咳糖漿存在污染物。世界衛生組織在 2022 年 7 月收到有關可能受到污染的報告後，對特定批次糖漿的樣本進行了測試。 Fourrts Laboratories 代表印度另一家名為 Dabilife Pharma 的公司生產止咳糖漿。這些嚴格的法規和檢查將提高產品質量，預計將在未來幾年推動止咳糖漿市場收入。

策略聯盟

著名的關鍵參與者正在進行併購，並不斷致力於新產品的開發，這些新產品通常由具有增強免疫力作用的天然成分和草藥配製而成。這反過來又推動市場向前發展。例如，2023 年，葛蘭素史克公司 (GSK plc)。與加拿大生技公司之一 Bellus Health 簽署了 20 億美元的收購協議。這筆交易的目的是加強葛蘭素史克的臨床產品組合和全球市場地位。該產品組合還包括糖漿和其他配方，從而提高了止咳糖漿的市場佔有率。同樣，2023 年 12 月，美國 FDA 就默克公司針對治療成人難治性慢性咳嗽（RCC）的藥物之一吉法匹克新藥申請（NDA）發布了完整回复函（CRL）。主要參與者正在進一步推出含有天然成分的止咳糖漿，以擴大其消費群，這是止咳糖漿市場的最新發展。例如，Vitae Health Innovation 推出了 VITATUSS，這是一種由接骨木漿果、百里香、木犀草、錦葵和沙棘萃取物配製而成的天然糖漿。同時，Sun Pharmaceutical Industries Ltd. 宣布推出一種名為 Chericof 12 的止咳配方。

全球止咳糖漿市場區隔：

IMARC Group提供了每個細分市場的主要趨勢分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據產品類型、年齡層和配銷通路對市場進行了分類。

按產品類型分類：

祛痰藥

止咳藥/鎮咳藥

聯合用藥

目前，止咳藥/鎮咳藥佔全球大部分市場佔有率

該報告根據產品類型對市場進行了詳細的細分和分析。這包括祛痰藥、止咳藥/鎮咳藥和合併用藥。報告顯示，止咳藥/鎮咳藥佔最大的市場佔有率。

與感冒和咳嗽相關的症狀通常可以透過使用非處方藥 (OTC) 來控制。止咳藥或鎮咳藥是用來控制和緩解咳嗽的藥物。雖然許多鎮咳藥可以透過非處方藥廣泛獲得，但也有一些鎮咳藥只能憑處方購買。鎮咳藥有多種劑型，例如膠囊、液體、片劑和糖漿。例如，在一項雙盲交叉試驗中，對美國最廣泛使用的止咳藥之一右美沙芬與歐洲傳統鎮咳藥可待因進行了比較，該試驗對16 名慢性咳嗽患者進行了主觀和客觀療效評估。右美沙芬比可待因更能降低咳嗽強度，被大多數患者認為是更好的止痛藥。反過來，這代表了推動止咳糖漿市場區隔的關鍵因素。

按年齡層別分類：

兒科

成人

成人目前佔據最大的市場佔有率

該報告根據年齡層對市場進行了詳細的細分和分析。這包括兒童和成人。報告稱，成人佔據最大的市場佔有率。

由於不健康的生活方式和大量接觸菸草，成年人通常患有慢性和急性咳嗽。例如，根據歐洲呼吸學會2020年發表的研究，由於生活品質受損，約有10%的成年人患有慢性咳嗽。因此，不斷擴大的成年人口正在增加止咳糖漿的市場需求，從而刺激止咳藥物的採用。

按配銷通路分類：

零售藥房

醫院藥房

網路藥房

目前，零售藥局在市場上佔據明顯主導地位

該報告根據配銷通路對市場進行了詳細的細分和分析。這包括零售藥房、醫院藥房和網路藥房。報告顯示，零售藥局佔據了最大的市場佔有率。

根據止咳糖漿市場概況，由於其可及性和便利性，透過零售藥房等分銷管道可以輕鬆獲得產品，這正在促進細分市場的成長。例如，根據德國藥劑師協會聯邦聯盟(ABDA) 的數據，到2023 年，德國各地約有18,068 家社區藥局滿足醫療需求。治療產品數量不斷增加Stores Inc. 和沃爾格林 (Walgreens) 進一步成為另一個重要的成長誘導因素，此外，醫院與這些連鎖店的合作不斷增加，也增強了止咳糖漿市場的近期價格。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

根據止咳糖漿市場統計，亞太地區在市場上表現出明顯的主導地位

市場研究報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告顯示，亞太地區佔據最大的市場佔有率。

區域市場主要由製藥公司和政府組織之間的眾多合作夥伴關係推動，通常是為了開發新型學名藥並提高個人和醫療保健專業人員的認知。此外，主要參與者正在強調創新的包裝解決方案，這有助於市場的成長。除此之外，該地區個人支出能力的膨脹以及對預防性醫療保健的日益關注進一步驗證了止咳糖漿市場的預測。根據 FMCG Gurus 的報告，自 COVID-19 大流行突然爆發以來，亞太地區超過 55% 的人更加自覺地增強免疫力。

本報告回答的關鍵問題

2023年全球止咳糖漿市場規模有多大？ 2024-2032年全球止咳糖漿市場的預期成長率是多少？
COVID-19 對全球止咳糖漿市場有何影響？
推動全球止咳糖漿市場的關鍵因素是什麼？
根據產品類型，全球止咳糖漿市場的詳細情形如何？
全球止咳糖漿市場依年齡層分類是怎樣的？
根據配銷通路，全球止咳糖漿市場的詳細情形如何？
全球止咳糖漿市場的關鍵地區有哪些？
誰是全球止咳糖漿市場的主要參與者/公司？

The global cough syrup market size reached US$ 5.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.4 Billion by 2032, exhibiting a growth rate (CAGR) of 3.8% during 2024-2032. The increasing occurrence of upper respiratory tract infections (URTIs) and other respiratory disorders, along with the easy availability of cough syrups in general stores and pharmacies, is primarily driving the market growth.

Global Cough Syrup Market Analysis:

Major Market Drivers: The expanding geriatric population who are more susceptible to developing respiratory disorders is primarily driving the market. Additionally, the increasing health consciousness among individuals is also acting as another significant growth-inducing factor.

Key Market Trends: Product manufacturers are introducing enhanced variants fortified with natural ingredients and herbs with immunity-boosting effects, which is one of the key trends propelling the global market. Besides this, the launch of cough syrups with minimal side effects is further strengthening the market.

Geographical Trends: Asia-Pacific currently dominates the global market, on account of the elevating healthcare expenditure capacities of individuals across the region. Apart from this, the growing focus on cough remedies is positively influencing the market growth.

Competitive Landscape: Some of the prominent cough syrup market companies include Acella Pharmaceuticals LLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Pfizer Inc., Prestige Consumer Healthcare Inc., Reckitt Benckiser Group PLC, Sanofi, Sun Pharmaceutical Industries Limited, and the Procter & Gamble Company, among many others.

Challenges and Opportunities: Primary challenges, such as the rising need to navigate a complex regulatory environment and the elevating concerns over the abuse and misuse of cough syrups containing opioids or other psychoactive ingredients, are hindering the overall market. However, the continuous growth of the pharmaceutical industry will continue to propel the global market in the coming years.

Global Cough Syrup Market Trends:

Growing Medical Conditions

The rising prevalence of cold, flu, bronchitis, pertussis, asthma, chronic pulmonary obstructive disease (COPD), and allergies is driving the need for cough syrups. For example, according to an article published by the Economic Times in 2023, around 339 million individuals are affected by asthma globally. Furthermore, the elevating cough cases, owing to the increasing tobacco consumption and unhealthy lifestyles, are also stimulating the market growth. Besides this, as per the World Health Organization (WHO), every year, more than 8 million people die prematurely from tobacco consumption. Among these, 7 million are direct smokers, and 1.7 million are second-hand smokers. Consequently, government and non-government organizations are launching numerous programs and campaigns to generate awareness among the population. For example, in July 2023, the Lung Foundation in Australia launched a chronic cough awareness campaign to raise awareness and support diagnosis in adults and pediatrics. In addition to this, the expanding geriatric population is further contributing to the cough syrup market outlook. For instance, according to the WHO, individuals aged 60 and above were 1 billion in 2020 and are expected to reach 2.1 billion by 2050.

Regulatory Environment by Government Bodies

Regulatory authorities across countries are implementing stringent rules to ensure leading companies of cough syrups comply with high medical standards. In line with this, they are generating awareness among healthcare professionals to develop generic drugs, thereby catalyzing the cough syrup market recent opportunities. For instance, in a letter written to all states and union territories, the Drugs Controller General of India (DCGI) asked to ensure that cough syrups produced in India are of global standard quality for which a detailed verification should be undertaken. In line with this, he asked for a joint verification drive on propylene glycol (PG) manufacturers, cough syrup manufacturers, and importers to ensure that the raw material utilized or supplied for the manufacturing of cough syrups is as per the global protocol. Additionally, the World Health Organization (WHO) has flagged another cough syrup for the presence of contaminants. The WHO tested a sample from a specific batch of the syrup after it received a report in July 2022 regarding possible contamination. Fourrts Laboratories produced the cough syrup on behalf of another company in India called Dabilife Pharma. These stringent regulations and checks will improve the quality of products, which is expected to propel the cough syrup market revenue in the coming years.

Strategic Alliances

Prominent key players are entering into mergers and acquisitions and are constantly working towards novel product developments that are usually formulated with natural ingredients and herbs with immunity-boosting effects. This, in turn, is driving the market forward. For example, in 2023, GSK plc. signed an acquisition deal with one of the Biotech firms in Canada, Bellus Health, for US$ 2 Billion. This deal was done to strengthen GSK's clinical pipeline portfolio and market position across the globe. The portfolio also included syrups and other formulations, thereby elevating the cough syrup market share. Similarly, in December 2023, the U.S. FDA issued a complete response letter (CRL) about Merck's new drug application (NDA) for gefapixant, one of the drugs to treat refractory chronic cough (RCC) in adults. Key players are further introducing cough syrups with natural ingredients to expand their consumer base, which is cough syrup market recent developments. For instance, Vitae Health Innovation launched VITATUSS, a natural syrup formulated with elderberry, thyme, althaea, mallow, and sea buckthorn extract. In line with this, Sun Pharmaceutical Industries Ltd. announced the introduction of a formulation in cough management called Chericof 12. The company said this was the first prescription cough syrup across India that offer relief for up to 12 hours.

Global Cough Syrup Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on the product type, age group and distribution channel.

Breakup by Product Type:

Expectorants

Cough Suppressants/Antitussives

Combination Medications

Currently, cough suppressants/antitussives account for the majority of the global market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes expectorants, cough suppressants/antitussives, and combination medications. According to the report, cough suppressants/antitussives accounted for the largest market share.

Symptoms related to cold and cough are usually managed by utilizing over the counter (OTC) medicines. Cough suppressants, or antitussive drugs, are medicines that are adopted to control and relieve a cough. While many antitussives are widely accessible OTC, a few antitussives are only available with a prescription. Antitussives are used in various types of formulations, such as capsules, liquids, tablets, and syrups. For example, Dextromethorphan, one of the most widely utilized cough suppressants in the U.S., was compared with codeine, the traditional antitussive in Europe, in a double-blind, crossover trial using both subjective and objective assessment of efficacy in sixteen patients with chronic cough. Dextromethorphan lowered cough intensity more than codeine and was considered the better antitussive by most patients. This, in turn, represents key factors propelling the cough syrup market growth in the segmentation.

Breakup by Age Group:

Pediatric

Adult

Adult currently holds the largest market share

The report has provided a detailed breakup and analysis of the market based on the age group. This includes pediatric and adult. According to the report, adult accounted for the largest market share.

Adults commonly suffer from chronic and acute cough, owing to unhealthy lifestyles and high exposure to tobacco. For example, as per the study published by the European Respiratory Society in 2020, approximately 10% of the adult population suffers from chronic cough, on account of the impaired quality of life. Consequently, the expanding adult population is escalating the cough syrup market demand, thereby stimulating the adoption of cough remedies.

Breakup by Distribution Channel:

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Currently, retail pharmacy exhibits a clear dominance in the market

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes retail pharmacy, hospital pharmacy, and online pharmacy. According to the report, retail pharmacy accounted for the largest market share.

As per the cough syrup market overview, the easy product availability via distribution channels, such as retail pharmacy, owing to its accessibility and convenience, is bolstering the segmentation growth. For example, according to the Federal Union of German Associations of Pharmacists (ABDA, around 18,068 community pharmacies across Germany cater to medical needs in 2023. In addition to this, the rising number of generic and branded remedy products in retail pharmacy chains, including Walmart Stores Inc. and Walgreens, is further acting as another significant growth-inducing factor. Moreover, the increasing tie-ups of hospitals with these chains are strengthening the cough syrup market recent price.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

According to the cough syrup market statistics, Asia Pacific exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific accounted for the largest market share.

The regional market is primarily driven by the numerous partnerships among pharmaceutical companies and government organizations, generally to develop novel generic drugs and generate awareness among individuals and healthcare professionals. Moreover, key players are emphasizing on innovative packaging solutions, which is contributing to the growth of the market. Apart from this, the inflating expenditure capacities of individuals across the region and the elevating focus on preventive healthcare are further validating the cough syrup market forecast. According to a report by the FMCG Gurus, more than 55% of people in the Asia Pacific region have been more conscious about boosting their immunity since the sudden outbreak of the COVID-19 pandemic.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Acella Pharmaceuticals LLC

Bayer AG

GlaxoSmithKline PLC

Johnson & Johnson

Pfizer Inc.

Prestige Consumer Healthcare Inc.

Reckitt Benckiser Group PLC

Sanofi

Sun Pharmaceutical Industries Limited

The Procter & Gamble Company

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Global Cough Syrup Market News:

April 2024: The World Health Organization (WHO) issued a broader alert regarding contaminated children's cough syrup produced by Johnson and Johnson in response to the discovery of tainted batches in Nigeria.

March 2024: Nin Jiom, one of the Hong Kong-based companies known for its cough syrup product Pei Pa Koa, is venturing into the healthy aging supplement space with a nicotinamide mononucleotide (NMN) product set to launch in Singapore.

November 2023: Himalaya Wellness Company announced the launch of Himalaya Koflet's 360-degree advertising campaign to enhance brand awareness.

Key Questions Answered in This Report

1. What was the size of the global cough syrup market in 2023?
2. What is the expected growth rate of the global cough syrup market during 2024-2032?
3. What has been the impact of COVID-19 on the global cough syrup market?
4. What are the key factors driving the global cough syrup market?
5. What is the breakup of the global cough syrup market based on the product type?
6. What is the breakup of the global cough syrup market based on the age group?
7. What is the breakup of the global cough syrup market based on the distribution channel?
8. What are the key regions in the global cough syrup market?
9. Who are the key players/companies in the global cough syrup market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Cough Syrup Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Expectorants
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Cough Suppressants/Antitussives
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Combination Medications
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Age Group

7.1 Pediatric
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Adult
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

8.1 Retail Pharmacy
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Hospital Pharmacy
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Online Pharmacy
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Acella Pharmaceuticals LLC
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
- 14.3.2 Bayer AG
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
- 14.3.3 GlaxoSmithKline PLC
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Johnson & Johnson
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Pfizer Inc.
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Prestige Consumer Healthcare Inc.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Reckitt Benckiser Group PLC
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Sanofi
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Sun Pharmaceutical Industries Limited
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 The Procter & Gamble Company
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Cough Syrup Market: Major Drivers and Challenges
Figure 2: Global: Cough Syrup Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Cough Syrup Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Cough Syrup Market: Breakup by Product Type (in %), 2023
Figure 5: Global: Cough Syrup Market: Breakup by Age Group (in %), 2023
Figure 6: Global: Cough Syrup Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Cough Syrup Market: Breakup by Region (in %), 2023
Figure 8: Global: Cough Syrup (Expectorants) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Cough Syrup (Expectorants) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Cough Syrup (Cough Suppressants/Antitussives) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Cough Syrup (Cough Suppressants/Antitussives) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Cough Syrup (Combination Medications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Cough Syrup (Combination Medications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Cough Syrup (Pediatric) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Cough Syrup (Pediatric) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Cough Syrup (Adult) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Cough Syrup (Adult) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Cough Syrup (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Cough Syrup (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Cough Syrup (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Cough Syrup (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Cough Syrup (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Cough Syrup (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: North America: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: North America: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: United States: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: United States: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Canada: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Canada: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Asia-Pacific: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Asia-Pacific: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: China: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: China: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Japan: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Japan: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: India: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: India: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: South Korea: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: South Korea: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Australia: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Australia: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Indonesia: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Indonesia: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Others: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Others: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Europe: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Europe: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Germany: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Germany: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: France: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: France: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: United Kingdom: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: United Kingdom: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Italy: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Italy: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Spain: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Spain: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Russia: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Russia: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Others: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Others: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Latin America: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Latin America: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Brazil: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Brazil: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Mexico: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Mexico: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Middle East and Africa: Cough Syrup Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Middle East and Africa: Cough Syrup Market: Breakup by Country (in %), 2023
Figure 72: Middle East and Africa: Cough Syrup Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Global: Cough Syrup Industry: SWOT Analysis
Figure 74: Global: Cough Syrup Industry: Value Chain Analysis
Figure 75: Global: Cough Syrup Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cough Syrup Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Cough Syrup Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
Table 3: Global: Cough Syrup Market Forecast: Breakup by Age Group (in Million US$), 2024-2032
Table 4: Global: Cough Syrup Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Cough Syrup Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Cough Syrup Market: Competitive Structure
Table 7: Global: Cough Syrup Market: Key Players

02-2729-4219

+886-2-2729-4219